| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/15/2008 | WO2008029237A3 Combination therapies for rheumatoid arthritis |
| 05/15/2008 | WO2007135542A3 Progastrin inhibitors in the treatment of colon cancer |
| 05/15/2008 | WO2007092270B1 Combination therapy for coronary artery disease |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/15/2008 | US20080114011 Enhancement of Effectiveness of 5-Fluorouracil in Treatment of Tumor Metastases and Cancer |
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113908 Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases |
| 05/15/2008 | US20080113902 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 05/15/2008 | US20080113899 Iron Supplement and Utilization of the Same |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113039 synergistic mixture of 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline and a platinum antitumor agent selected from cisplatin, carboplatin or oxaliplatin, for the treatment of cancers; angiogenesis inhibitors and vascular permeability reducing effect in mammals |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113022 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112918 Method for treating gout and binding uric acid |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | CA2668607A1 Nonoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/15/2008 | CA2668162A1 Use of organic compounds |
| 05/15/2008 | CA2665778A1 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1920774A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920771A2 Methods of treating hyperlipidemia |
| 05/14/2008 | EP1920764A1 Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension |
| 05/14/2008 | EP1919505A2 Single dose use of cd20-specific binding molecules |
| 05/14/2008 | EP1919481A2 Therapy for neurological diseases |
| 05/14/2008 | EP1919466A2 Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative |
| 05/14/2008 | EP1919450A1 Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| 05/14/2008 | EP1696825A4 Use of alginate matrices to control cell growth |
| 05/14/2008 | EP1513525B1 Use of mglur5 antagonists for the treatment of gerd |
| 05/14/2008 | EP1506009B1 Beta-glucan-based anti-fungal vaccines |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | EP1305031B1 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1267867B1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1021148B1 Composition and method for acceleration of wound and burn healing |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | CN101180080A Nutritive composition including green tea polyphenol for treating osteosarcoma |
| 05/14/2008 | CN101180061A Compounds, and compositions containing the compounds, and method for treatment of metastatic melanoma and other cancers |
| 05/14/2008 | CN101180059A Combination of indacaterol derivates for curing air flue disease and other matters |
| 05/14/2008 | CN101180058A Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases |
| 05/14/2008 | CN101176788A Pharmaceutical composition for ACE restrainer/uretica/folic acid, and uses thereof |
| 05/14/2008 | CN101176787A Method for chemoprevention of prostate cancer |
| 05/14/2008 | CN101176786A Method and composition for increasing insulin sensibility |
| 05/14/2008 | CN101176726A Medicine-loading sustained-release micro-capsule and preparing method thereof |
| 05/14/2008 | CN101176717A Temperature control gel rubber sustained-release injection containing resist metabolism series medicine |
| 05/14/2008 | CN101176706A Temperature control sustained-release injection containing resist metabolism series medicine |
| 05/14/2008 | CN100387574C Preparation of sodium probenecid and potassium probenecid |
| 05/14/2008 | CN100387296C New dialysis method |
| 05/14/2008 | CN100387222C Solid preparation for dialysis and process for producing the same |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371734 Oligonucleotide compositions and their use for the modulation of immune responses |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371529 Methods and compositions for modulating gluconeogenesis using PGC-1 |
| 05/13/2008 | US7371407 the oil is used as a carrying agent for anti-microbial formulations; comprises terbinafine and other antibiotics; for topical application to the skin or mucosal membranes of a mammal |
| 05/13/2008 | US7371395 Vaccine formulations |
| 05/13/2008 | US7371390 Vaccine of a hepatitis B viral (HBV) antigen and a human papillomavirus (HPV) antigen with an adjuvant which is a preferential stimulator of TH1 cell response such as QS21 (a Quillaja saponaria saponin); free of a herpes simplex viral antigen; vaccine for adolescents e.g. against cervical cancer |
| 05/13/2008 | US7371385 Method of treating immune pathologies with low dose estrogen |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | US7371372 Inosine monophosphate dehydrogenase inhibitor and interferon; hepatitis C |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders |
| 05/13/2008 | CA2469343C Combination of cytochome p450 dependent protease inhibitors |
| 05/13/2008 | CA2468449C Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 05/13/2008 | CA2378490C Antibiotic/antibiotics (or: antibiotic(s)) preparation with retarding active ingredient release |
| 05/13/2008 | CA2344222C Adhesive protein foam for surgical and/or therapeutic uses |
| 05/13/2008 | CA2250919C Photopheresis treatment of leukocytes |
| 05/13/2008 | CA2223438C Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 05/13/2008 | CA2222278C Mineral supplements for dietetic food |
| 05/13/2008 | CA2212058C Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease |
| 05/13/2008 | CA2206119C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/08/2008 | WO2008055022A2 Carbamate compounds for use in treating depression |
| 05/08/2008 | WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 05/08/2008 | WO2008054192A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053352A2 Phenylpropionamide compounds and the use thereof |
| 05/08/2008 | WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 05/08/2008 | WO2008052295A1 Process for the preparation of compounds of at1 receptor antagonists with angiotensin-(1-7), analogues thereof and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products |
| 05/08/2008 | WO2008052277A1 Crystalline composition of gm-csf/gm-csfr |
| 05/08/2008 | WO2007149381A3 Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer |
| 05/08/2008 | WO2007139887A3 Methods for treating bone or joint inflammation |
| 05/08/2008 | WO2007060038A3 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/08/2008 | US20080108796 Human IL-1 epsilon DNA and polypeptides |